Skip to main content
Journal cover image

Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.

Publication ,  Journal Article
Caster, JM; Patel, AN; Zhang, T; Wang, A
Published in: Wiley Interdiscip Rev Nanomed Nanobiotechnol
January 2017

Nanomedicine is a relatively new field that is rapidly evolving. Formulation of drugs on the nanoscale imparts many physical and biological advantages. Such advantages can in turn translate into improved therapeutic efficacy and reduced toxicity. While approximately 50 nanotherapeutics have already entered clinical practice, a greater number of drugs are undergoing clinical investigation for a variety of indications. This review aims to examine all the nanoformulations that are currently undergoing clinical investigation and their outlook for ultimate clinical translation. WIREs Nanomed Nanobiotechnol 2017, 9:e1416. doi: 10.1002/wnan.1416 For further resources related to this article, please visit the WIREs website.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Wiley Interdiscip Rev Nanomed Nanobiotechnol

DOI

EISSN

1939-0041

Publication Date

January 2017

Volume

9

Issue

1

Location

United States

Related Subject Headings

  • Nanoscience & Nanotechnology
  • Nanomedicine
  • Mice
  • Humans
  • Drugs, Investigational
  • Drug Evaluation
  • Disease Models, Animal
  • Clinical Trials as Topic
  • Animals
  • 4018 Nanotechnology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Caster, J. M., Patel, A. N., Zhang, T., & Wang, A. (2017). Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 9(1). https://doi.org/10.1002/wnan.1416
Caster, Joseph M., Artish N. Patel, Tian Zhang, and Andrew Wang. “Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.Wiley Interdiscip Rev Nanomed Nanobiotechnol 9, no. 1 (January 2017). https://doi.org/10.1002/wnan.1416.
Caster JM, Patel AN, Zhang T, Wang A. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1).
Caster, Joseph M., et al. “Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.Wiley Interdiscip Rev Nanomed Nanobiotechnol, vol. 9, no. 1, Jan. 2017. Pubmed, doi:10.1002/wnan.1416.
Caster JM, Patel AN, Zhang T, Wang A. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1).
Journal cover image

Published In

Wiley Interdiscip Rev Nanomed Nanobiotechnol

DOI

EISSN

1939-0041

Publication Date

January 2017

Volume

9

Issue

1

Location

United States

Related Subject Headings

  • Nanoscience & Nanotechnology
  • Nanomedicine
  • Mice
  • Humans
  • Drugs, Investigational
  • Drug Evaluation
  • Disease Models, Animal
  • Clinical Trials as Topic
  • Animals
  • 4018 Nanotechnology